Robotic Prostatectomy and Prostate Cancer-Related Medicaid Spending: Evidence from New York State.
Journal:
Journal of general internal medicine
PMID:
33751413
Abstract
BACKGROUND: Robotic prostatectomy is a costly new technology, but the costs may be offset by changes in treatment patterns. The net effect of this technology on Medicaid spending has not been assessed.